Clinical trial
Treatment of Refractory Schizophrenia With Riluzole
NCT00375050 · Yale University, Other · Completed
Key facts
| NCT number | NCT00375050 |
|---|---|
| Title | Treatment of Refractory Schizophrenia With Riluzole |
| Official title | Neuroprotective Treatment of Refractory Schizophrenia With Riluzole 01T-432 |
| Lead sponsor | Yale University, Other |
| Collaborators | Stanley Medical Research Institute |
| Status | Completed |
| Study type | Interventional |
| Conditions | Schizophrenia, Schizoaffective |
| Intervention type | Drug |
| Interventions | Riluzole, Placebo |
| Enrollment | 34 |
| Start date | May 1, 2002 |
| Primary completion | Aug 29, 2006 |
| Completion | Aug 29, 2006 |
| First posted | Sep 12, 2006 |
| Last update posted | Dec 9, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: